HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Ironwood Pharmaceuticals, Inc. discovers, develops, and commercializes medicines targeting therapeutic needs. The company is developing Linaclotide, a first-in-class compound that is in confirmatory Phase III clinical trials for the treatment of irritable bowel syndrome with constipation, chronic constipation, and other lower gastrointestinal conditions. It also focuses on one Phase I pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. The company has a collaboration agreement with Forest Laboratories, Inc. to jointly develop and commercialize linaclotide in North America; a license agreement with Almirall, S.A. to develop and commercialize linaclotide in Europe; a license agreement with Astellas Pharma Inc. that provides Astellas Pharma with the right to develop and commercialize linaclotide in Japan, South Korea, Taiwan, Thailand, the Philippines, and Indonesia. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.
Market Cap | 1.708 Billion | Shares Outstanding | 160.962 Million | Avg 30-day Volume | 1.759 Million | ||
P/E Ratio | 16.0847 | Dividend Yield | 0.0 | EPS | 0.661 | ||
Price/Sales | 4.21 | Debt to Equity | 8.93 | EBITDA | 161.886 Million | ||
Price to Book Value | 26.18 | Forward PE | 10.61 | Enterprise Value | 1.708 Billion | ||
Total Cash | 362.564 Million | Current Debt | 32.173 Million | Gross Profit | 386.387 Million | ||
BETA | 0.69731 | 52-week High/Low | 12.55 / 8.63 | Next Earnings Date | 2021-05-05 | Price to Cash FLow (P/CF) | -9999999.0 |
Data provided by IEX Cloud |
Q4 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 3 | 2 | 50.0% | 2 (0.12%) | 2 (0.12%) | 0.0% |
Funds Holding: | 201 | 189 | 6.35% | 63 (3.79%) | 62 (3.86%) | 1.61% |
13F shares: | 171.051 Million | 169.856 Million | 0.7% | 78.782 Million | 73.273 Million | 7.52% |
% Ownership | 49.2087 | 45.7679 | 7.52% | |||
New Positions: | 40 | 24 | 66.67% | 13 | 10 | 30.0% |
Increased Positions | 67 | 67 | 0.0% | 26 | 23 | 13.04% |
Closed Positions | 28 | 36 | -22.22% | 12 | 17 | -29.41% |
Reduced Positions | 61 | 64 | -4.69% | 20 | 22 | -9.09% |
Total Calls | 1.295 Million | 1.355 Million | -4.39% | 108.6 Thousand | 500 Thousand | -78.28% |
Total Puts | 559.566 Thousand | 621.543 Thousand | -9.97% | 542.5 Thousand | 538.3 Thousand | 0.78% |
PUT/CALL Ratio | 0.43 | 0.46 | -6.52% | 5.0 | 1.08 | 362.96% |
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
2.4 Million total shares from 11 transactions
88.8 Thousand total shares from 19 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
125,607 | 2021-04-20 | 3 | |
MCCOURT THOMAS A PRESIDENT AND INTERIM CEO |
|
568,215 | 2021-03-26 | 5 |
CONSYLMAN GINA SVP, CFO & TREASURER |
|
392,616 | 2021-03-26 | 4 |
RICKARD JASON SVP, CHIEF OPERATING OFFICER |
|
363,054 | 2021-03-26 | 6 |
SHETZLINE MICHAEL CMO, SVP & HEAD OF DRUG DEVT. |
|
199,514 | 2021-03-26 | 4 |
|
109,097 | 2021-03-15 | 5 | |
|
48,994 | 2021-03-15 | 2 | |
|
16,429,079 | 2021-03-15 | 7 | |
|
258,954 | 2021-02-26 | 3 | |
MALLON MARK CHIEF EXECUTIVE OFFICER |
|
470,605 | 2021-02-26 | 2 |
KILROY CONOR SVP, GC & SECRETARY |
|
122,336 | 2021-02-26 | 4 |
|
15,427,844 | 2021-02-26 | 7 | |
MACDONALD KELLY CHIEF ACCOUNTING OFFICER |
|
93,041 | 2020-12-04 | 6 |
|
35,557 | 2020-12-03 | 2 | |
|
68,629 | 2020-06-10 | 2 | |
|
570,992 | 2020-06-03 | 1 | |
|
47,421 | 2020-06-03 | 1 | |
|
47,421 | 2020-06-03 | 1 | |
GILBERT HALLEY E CHIEF ADMIN OFFICER & SVP |
|
265,991 | 2020-02-21 | 0 |
|
144,373 | 2019-04-01 | 0 | |
HECHT PETER M CHIEF EXECUTIVE OFFICER |
|
0 | 2019-04-01 | 0 |
|
132,663 | 2019-04-01 | 0 | |
|
87,800 | 2019-04-01 | 0 | |
|
38,242 | 2019-04-01 | 0 | |
HUYETT WILLIAM CHIEF OPERATING OFFICER |
|
27,546 | 2019-04-01 | 0 |
|
374,525 | 2017-03-15 | 0 | |
GRANEY THOMAS CHIEF FINANCIAL OFFICER |
|
42,013 | 2017-02-27 | 0 |
|
123,978 | 2015-06-15 | 0 | |
|
635,976 | 2015-06-03 | 0 | |
|
101,233 | 2015-03-13 | 0 | |
|
328,080 | 2015-03-11 | 0 | |
HIGGINS MICHAEL J CHIEF OPERATING OFFICER |
|
329,102 | 2014-12-23 | 0 |
|
393,455 | 2014-03-14 | 0 | |
|
No longer subject to file | 2013-03-28 | 0 | |
|
No longer subject to file | 2013-03-15 | 0 | |
VHCP CO-INVESTMENT HOLDINGS, LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP |
|
No longer subject to file | 2013-03-15 | 0 |
|
2,340,891 | 2012-07-09 | 0 | |
RIDGEBACK CAPITAL INVESTMENTS L.P. |
|
No longer subject to file | 2012-02-02 | 0 |
|
42,667 | 2011-03-31 | 0 | |
VENROCK MANAGEMENT LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP |
|
8,731,321 | 2010-02-02 | 0 |
|
770,952 | 2010-02-02 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-04-22 16:02:23 -0400 | 2021-04-20 | A | 2,500 | a | 125,607 | direct | ||||||||||
2021-03-30 17:07:38 -0400 | 2021-03-26 | A | 96,638 | a | 568,215 | direct | -2.6834 | -7.5134 | 0.0 | 1 | -7.5134 | 6 | ||||
2021-03-30 17:09:56 -0400 | 2021-03-26 | A | 38,655 | a | 199,514 | direct | -2.6834 | -7.5134 | 0.0 | 1 | -7.5134 | 6 | ||||
2021-03-30 17:06:12 -0400 | 2021-03-26 | A | 56,372 | a | 392,616 | direct | -2.6834 | -7.5134 | 0.0 | 1 | -7.5134 | 6 | ||||
2021-03-30 17:08:41 -0400 | 2021-03-26 | A | 56,372 | a | 363,054 | direct | -2.6834 | -7.5134 | 0.0 | 1 | -7.5134 | 6 | ||||
2021-03-17 16:01:22 -0400 | 2021-03-15 | A | 1,573 | a | 48,994 | direct | 0.2674 | -2.7629 | 2.6738 | 3 | -5.5258 | 5 | ||||
2021-03-17 16:08:48 -0400 | 2021-03-15 | A | 1,235 | a | 39,079 | direct | 0.2674 | -2.7629 | 2.6738 | 3 | -5.5258 | 5 | ||||
2021-03-17 16:03:53 -0400 | 2021-03-15 | A | 1,460 | a | 109,097 | direct | 0.2674 | -2.7629 | 2.6738 | 3 | -5.5258 | 5 | ||||
DENNER ALEXANDER J - Director - > 10% Owner see footnote SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote |
2021-03-10 19:06:57 -0500 | 2021-03-10 | P | 75,000 | $10.54 | a | 16,390,000 | indirect | 0.4885 | -0.3552 | 2.3979 | 5 | -1.1989 | 3 | ||
DENNER ALEXANDER J - Director - > 10% Owner see footnote SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote |
2021-03-10 19:06:57 -0500 | 2021-03-08 | P | 150,000 | $10.30 | a | 16,315,000 | indirect | 0.4885 | -0.3552 | 2.3979 | 5 | -1.1989 | 3 | ||
DENNER ALEXANDER J - Director - > 10% Owner see footnote SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote |
2021-03-05 19:19:46 -0500 | 2021-03-05 | P | 175,000 | $10.01 | a | 16,165,000 | indirect | 7.4437 | 8.9618 | 4.4074 | 12.9285 | 8 | -0.4897 | 25 | |
DENNER ALEXANDER J - Director - > 10% Owner see footnote SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote |
2021-03-05 19:19:46 -0500 | 2021-03-04 | P | 250,000 | $10.00 | a | 15,990,000 | indirect | 7.4437 | 8.9618 | 4.4074 | 12.9285 | 8 | -0.4897 | 25 | |
DENNER ALEXANDER J - Director - > 10% Owner see footnote SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote |
2021-03-05 19:19:46 -0500 | 2021-03-03 | P | 350,000 | $10.02 | a | 15,740,000 | indirect | 7.4437 | 8.9618 | 4.4074 | 12.9285 | 8 | -0.4897 | 25 | |
DENNER ALEXANDER J - Director see footnote |
2021-03-02 20:18:07 -0500 | 2021-03-02 | P | 500,000 | $9.56 | a | 15,390,000 | indirect | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
DENNER ALEXANDER J - Director see footnote |
2021-03-02 20:18:07 -0500 | 2021-03-01 | P | 344,900 | $9.60 | a | 14,890,000 | indirect | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
DENNER ALEXANDER J - Director see footnote |
2021-03-02 20:18:07 -0500 | 2021-02-26 | P | 505,100 | $9.20 | a | 14,545,100 | indirect | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:43:50 -0500 | 2021-02-26 | S | 6,159 | $9.11 | d | 306,682 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:43:50 -0500 | 2021-02-26 | S | 2,668 | $9.11 | d | 317,665 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:40:18 -0500 | 2021-02-26 | S | 1,838 | $9.11 | d | 481,842 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:37:55 -0500 | 2021-02-26 | S | 8,093 | $9.11 | d | 493,187 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:36:27 -0500 | 2021-02-26 | S | 1,474 | $9.11 | d | 126,452 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:34:50 -0500 | 2021-02-26 | S | 6,242 | $9.11 | d | 343,224 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:44:58 -0500 | 2021-02-26 | S | 3,041 | $9.11 | d | 160,859 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:43:50 -0500 | 2021-02-26 | S | 3,197 | $9.11 | d | 312,841 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:41:41 -0500 | 2021-02-26 | P | 3,000 | $8.90 | a | 218,954 | direct | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | ||
2021-03-02 16:40:18 -0500 | 2021-02-26 | S | 2,582 | $9.11 | d | 483,680 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:36:27 -0500 | 2021-02-26 | S | 1,848 | $9.11 | d | 122,336 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:36:27 -0500 | 2021-02-26 | S | 1,399 | $9.11 | d | 127,926 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:34:50 -0500 | 2021-02-26 | S | 2,527 | $9.11 | d | 349,466 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:44:58 -0500 | 2021-02-26 | S | 1,398 | $9.11 | d | 163,900 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:43:50 -0500 | 2021-02-26 | S | 1,627 | $9.11 | d | 316,038 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:40:18 -0500 | 2021-02-26 | S | 10,265 | $9.11 | d | 471,577 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:37:55 -0500 | 2021-02-26 | S | 22,582 | $9.11 | d | 470,605 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:36:27 -0500 | 2021-02-26 | S | 2,268 | $9.11 | d | 124,184 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:34:50 -0500 | 2021-02-26 | S | 6,980 | $9.11 | d | 336,244 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-03-02 16:34:50 -0500 | 2021-02-26 | S | 2,657 | $9.11 | d | 351,993 | direct | yes | 0.2006 | 5.8175 | 8.7262 | 15.6469 | 11 | 0.0 | 1 | |
2021-02-26 17:15:52 -0500 | 2021-02-25 | P | 5,000 | $9.11 | a | 215,954 | direct | -0.6257 | 6.4651 | 7.5078 | 20.2294 | 13 | -0.6257 | 2 | ||
2021-02-26 17:15:52 -0500 | 2021-02-24 | P | 7,000 | $9.26 | a | 210,954 | direct | -0.6257 | 6.4651 | 7.5078 | 20.2294 | 13 | -0.6257 | 2 | ||
2021-02-24 16:02:01 -0500 | 2021-02-22 | A | 84,951 | a | 354,650 | direct | 2.1018 | 10.5088 | 12.7212 | 27.5442 | 15 | 0.0 | 1 | |||
2021-02-24 16:11:56 -0500 | 2021-02-22 | A | 84,951 | a | 320,333 | direct | 2.1018 | 10.5088 | 12.7212 | 27.5442 | 15 | 0.0 | 1 | |||
2021-02-24 16:07:13 -0500 | 2021-02-22 | A | 145,631 | a | 486,262 | direct | 2.1018 | 10.5088 | 12.7212 | 27.5442 | 15 | 0.0 | 1 | |||
2021-02-24 16:17:52 -0500 | 2021-02-22 | A | 58,252 | a | 165,298 | direct | 2.1018 | 10.5088 | 12.7212 | 27.5442 | 15 | 0.0 | 1 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-23 14:45:03 UTC | -0.2529 | 0.3129 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-23 14:15:03 UTC | -0.2529 | 0.3129 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-23 13:45:03 UTC | -0.2529 | 0.3129 | 850000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-23 13:15:03 UTC | -0.2529 | 0.3129 | 850000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-23 12:45:02 UTC | -0.2529 | 0.3129 | 850000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 22:15:03 UTC | -0.2529 | 0.3129 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 21:45:04 UTC | -0.2217 | 0.2817 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 21:15:03 UTC | -0.2217 | 0.2817 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 20:45:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 20:15:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 19:45:02 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 19:15:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 18:45:02 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 18:15:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 17:45:02 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 17:15:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 16:45:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 16:15:02 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 15:45:03 UTC | -0.19 | 0.25 | 900000 |
IRONWOOD PHARMACEUTICALS INC IRWD | 2021-04-22 15:15:03 UTC | -0.19 | 0.25 | 900000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
AQR Funds- AQR Diversified Arbitrage Fund | IRWD | -133806.0 shares, $-1524050.34 | 2020-12-31 | N-PORT |
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund | IRWD | -89481.0 shares, $-1030821.12 | 2020-11-30 | N-PORT |
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio | IRWD | -10499.0 shares, $-119583.61 | 2020-12-31 | N-PORT |
JNL Series Trust- JNL Multi-Manager Alternative Fund | IRWD | -74479.0 shares, $-848315.81 | 2020-12-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | IRWD | -13.0 shares, $-131.17 | 2020-03-31 | N-PORT |
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund | IRWD | -1005487.0 shares, $-10276077.14 | 2021-01-31 | N-PORT |